Lead: Expanding Access to Buprenorphine and Methadone: Global Perspectives and Policy Recommendations cover art

Lead: Expanding Access to Buprenorphine and Methadone: Global Perspectives and Policy Recommendations

Lead: Expanding Access to Buprenorphine and Methadone: Global Perspectives and Policy Recommendations

Listen for free

View show details

About this listen

Expanding Access to Buprenorphine and Methadone: Global Perspectives and Policy Recommendations

Substance Use and Addiction Journal

This is a narrative review of methadone and buprenorphine regulations, prescriber eligibility, dispensing models, and coverage across eight countries: the United States, Canada, the United Kingdom, Russia, France, Iran, Australia, and Portugal. The study identified several key barriers to MOUD: requirements for daily supervised dosing, restricted community prescribing, and stigmatizing drug scheduling. The authors highlight policies that improved MOUD access without compromising safety such as: 1) community pharmacy dispensing supports in the U.K. and Australia, 2) liberal buprenorphine prescribing in primary care in France, and 3) decriminalization and expansion of low-threshold public health models in Portugal and Iran.

Read this issue of the ASAM Weekly

Subscribe to the ASAM Weekly

Visit ASAM
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.